iEmoji Feeds @Liver International (LiverInt)

1.

LiverInt
The liver ️ plays a central role in the relationship between the circadian timing system and metabolism

Abnormali… twitter.com/i/web/status/1…
06 Mar 23 copy & paste +upvote -downvote The liver 🕰️ plays a central role in the relationship between the circadian timing system and metabolism Abnormali… https://t.co/aIYJkJfUiU

2.

LiverInt
Opportunities of assessment and treatment of #NAFLD in primary care settings

ow.ly/KUE350LiqNk

twitter.com/i/web/status/1…
23 Oct 22 copy & paste +upvote -downvote Opportunities of assessment and treatment of #NAFLD in primary care settings 👉 https://t.co/cXJHFRiJVn ✍️… https://t.co/HXCy8m2bde
3.
LiverInt
Real-world safety and afficacy of #obeticolic acid in #PBC cirrhotic patients:

n=100
1/3 biochemical response… twitter.com/i/web/status/1…
15 Oct 22 copy & paste +upvote -downvote Real-world safety and afficacy of #obeticolic acid in #PBC cirrhotic patients: 🇮🇹 n=100 ✅ 1/3 biochemical response… https://t.co/lvaUU82PkS
4.
LiverInt
Safety and efficacy results of #alfapump in real-world patients with refractory #ascites not eligible for TIPS:… twitter.com/i/web/status/1…
25 Sep 22 copy & paste +upvote -downvote Safety and efficacy results of #alfapump® in real-world patients with refractory #ascites not eligible for TIPS:… https://t.co/aiW8BrN6jC
5.
LiverInt
The role of #ferroptosis in the pathophysiology of #MAFLD:

Iron overload and lipid peroxidation
Impact of ferr… twitter.com/i/web/status/1…
14 Jul 22 copy & paste +upvote -downvote The role of #ferroptosis in the pathophysiology of #MAFLD: 🔑 Iron overload and lipid peroxidation 🔑 Impact of ferr… https://t.co/Ld5RYHDgVW
6.
LiverInt
Take a look to our new review on the management of gastric varices:

Hemodynamic features
Primary prophylaxis… twitter.com/i/web/status/1…
11 Jun 22 copy & paste +upvote -downvote Take a look to our new review on the management of gastric varices: 🔑 Hemodynamic features 🔑 Primary prophylaxis… https://t.co/2Qh2S1u3vL
7.
LiverInt
Risk of cancer in #NAFLD patients:

n= 8.415 + 70.934 controls
Follow-up 6yrs
Risk of Hepatocellular Carc… twitter.com/i/web/status/1…
05 Apr 22 copy & paste +upvote -downvote 📈 Risk of cancer in #NAFLD patients: 🇸🇪 n= 8.415 + 70.934 controls ⏳ Follow-up 6yrs ⬆️ Risk of Hepatocellular Carc… https://t.co/HtkBk9dve2
8.
LiverInt
Cumulative incidence of #HCC in Scotland is declining in #hepatitisC cirrhosis patients but ...

n= 3347 p… twitter.com/i/web/status/1…
03 Mar 22 copy & paste +upvote -downvote Cumulative incidence of #HCC in Scotland is declining in #hepatitisC cirrhosis patients but ... 🏴󠁧󠁢󠁳󠁣󠁴󠁿 n= 3347 p… https://t.co/DszUyYBU0f
9.
LiverInt
Could we shorten glecaprevir/pibrentasvir #HepatitisC treatment to just 4 weeks?

Yes, but paying the price of a… twitter.com/i/web/status/1…
27 Nov 21 copy & paste +upvote -downvote Could we shorten glecaprevir/pibrentasvir #HepatitisC treatment to just 4 weeks? ❌ Yes, but paying the price of a… https://t.co/ejiFaZpsbA
10.
LiverInt
Risk of secondary sclerosing cholangitis in critically ill patients due to #COVID19 infection:

Retrospective c… twitter.com/i/web/status/1…
17 Oct 21 copy & paste +upvote -downvote Risk of secondary sclerosing cholangitis in critically ill patients due to #COVID19 infection: ✳️Retrospective 🇨🇭c… https://t.co/b4ub5LCqwS

...but wait! There's more!

1.

fakhright
fakhright @fakhright
astaghfirullah peng.krim guaaaaaaaa..............a *salto sambil solat*
14 Jan 13 copy & paste +upvote -downvote astaghfirullah peng.krim guaaaaaaaa..............a *salto sambil solat* 🙈🙈🙊
https://www.iemoji.com/feed/LiverInt
Back to top